CN1315391C - Milk powder and its preparing method - Google Patents
Milk powder and its preparing method Download PDFInfo
- Publication number
- CN1315391C CN1315391C CNB2004100483874A CN200410048387A CN1315391C CN 1315391 C CN1315391 C CN 1315391C CN B2004100483874 A CNB2004100483874 A CN B2004100483874A CN 200410048387 A CN200410048387 A CN 200410048387A CN 1315391 C CN1315391 C CN 1315391C
- Authority
- CN
- China
- Prior art keywords
- dry powder
- powder
- milk
- silybi mariani
- herba silybi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 115
- 235000013336 milk Nutrition 0.000 title claims abstract description 59
- 210000004080 milk Anatomy 0.000 title claims abstract description 59
- 239000008267 milk Substances 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims description 7
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 58
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 17
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 16
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 238000001694 spray drying Methods 0.000 claims abstract description 5
- 235000016709 nutrition Nutrition 0.000 claims description 16
- 241000320380 Silybum Species 0.000 claims description 13
- 210000000481 breast Anatomy 0.000 claims description 11
- 238000002372 labelling Methods 0.000 claims description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 238000012805 post-processing Methods 0.000 claims description 4
- 239000000052 vinegar Substances 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 235000021552 granulated sugar Nutrition 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 241000220215 Moringa Species 0.000 claims 12
- 244000179886 Moringa oleifera Species 0.000 abstract description 47
- 235000013305 food Nutrition 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 12
- 235000015097 nutrients Nutrition 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 2
- 244000272459 Silybum marianum Species 0.000 abstract 3
- 235000008476 powdered milk Nutrition 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 28
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 23
- 235000001014 amino acid Nutrition 0.000 description 22
- 229940024606 amino acid Drugs 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 150000001413 amino acids Chemical class 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 14
- 239000011575 calcium Substances 0.000 description 14
- 229910052791 calcium Inorganic materials 0.000 description 14
- 229910052742 iron Inorganic materials 0.000 description 14
- 229960003284 iron Drugs 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 235000012000 cholesterol Nutrition 0.000 description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 9
- 239000011591 potassium Substances 0.000 description 9
- 229910052700 potassium Inorganic materials 0.000 description 9
- 235000019155 vitamin A Nutrition 0.000 description 9
- 239000011719 vitamin A Substances 0.000 description 9
- 229940045997 vitamin a Drugs 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 239000011669 selenium Substances 0.000 description 7
- 229910052711 selenium Inorganic materials 0.000 description 7
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 7
- 229960004245 silymarin Drugs 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- 230000012010 growth Effects 0.000 description 6
- 235000017700 silymarin Nutrition 0.000 description 6
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 235000020776 essential amino acid Nutrition 0.000 description 5
- 239000003797 essential amino acid Substances 0.000 description 5
- 210000005229 liver cell Anatomy 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- 229930003471 Vitamin B2 Natural products 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- -1 seralbumin Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 235000019164 vitamin B2 Nutrition 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AQGDXJQRVOCUQX-UHFFFAOYSA-N N.[S] Chemical compound N.[S] AQGDXJQRVOCUQX-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- JOSHUAQJVMGTGS-UHFFFAOYSA-N Niazimicin A Chemical compound C1=CC(CNC(=S)OCC)=CC=C1OC1C(O)C(O)C(O)C(C)O1 JOSHUAQJVMGTGS-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010001515 Galectin 4 Proteins 0.000 description 1
- 102100039556 Galectin-4 Human genes 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- CYGIJEJDYJOUAN-UHFFFAOYSA-N Isosilychristin Natural products C1=C(O)C(OC)=CC(C2C3C=C(C4C(C3=O)(O)OCC42)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 244000287858 Moringa ovalifolia Species 0.000 description 1
- 241000339422 Moringa peregrina Species 0.000 description 1
- 241000339449 Moringa stenopetala Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 241001596291 Namibia Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 241000786103 Steatomys pratensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N THREONINE Chemical compound CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- SSFYJDHLXWLBOY-UHFFFAOYSA-N [Se].[Fe].[Zn].[Cu].[Mn].[Mg].[Ca] Chemical compound [Se].[Fe].[Zn].[Cu].[Mn].[Mg].[Ca] SSFYJDHLXWLBOY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 229940106589 milk thistle seed extract Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229950000628 silibinin Drugs 0.000 description 1
- 229950004878 silicristin Drugs 0.000 description 1
- 229950004304 silidianin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- BMLIIPOXVWESJG-LMBCONBSSA-N silychristin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC(=C3)[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-LMBCONBSSA-N 0.000 description 1
- BMLIIPOXVWESJG-UHFFFAOYSA-N silychristin A Natural products C1=C(O)C(OC)=CC(C2C(C3=C(C(=CC(=C3)C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-UHFFFAOYSA-N 0.000 description 1
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to milk powder and a preparation method thereof. The milk powder is prepared by that concentrated milk is obtained by concentrating fresh milk, and dry powdery milk is obtained through spray drying; after being processed through cooling and sieving, the dry powdery milk is proportionally mixed with dry horseradish tree leaf powder and dry carduus marianus seed powder; a milk powder product is obtained through post treatment, wherein a mixture of horseradish tree leaf extract and carduus marianus seed extract has a composition by weight: 0 to 99% of the horseradish tree leaf extract and 1% to 100% of the carduus marianus seed extract. Compared with a similar product, the nutrient effect and the health-care effect of the powdered milk of the present invention are markedly increased. The present invention has the effects of dietetic therapy, health care and nutrient increase, and is a good quality blood nourishing food.
Description
Technical field:
The present invention relates to a kind of milk powder and preparation method thereof, specifically, is a kind of milk powder product that has mixed plant extracts and preparation method thereof, belongs to the edible extract field.
Background technology:
Moringa (Moringa oleifera) is a Moringaceae Moringa plant, is a kind of tropical plants that unique economic worth is arranged.Undergraduate course only has a genus, totally 14 kinds.Wherein M.stenopetala (originating in Ethiopia and Kenya the north), M.peregrina (originating in the Sudan, Egypt and the Arabia Peninsula), M.ovalifolia (originating in Angola and Namibia) and Moringa oleifera (originating in the inferior Himalaya of north India zone) wait four kinds of existing cultivations, and growth fast, distribute extensively and utilization and to study maximum be Moringa oleifera.
Moringa blade, fruit pod are rich in several mineral materials, vitamin, as vegetables and food augment nutritional and Dietotherapy health function are arranged; The record that eats or utilize Moringa is just arranged as far back as ancient Roman period, over the past thousands of years, Moringa is developed, is being utilized by people as nutraceutical, medicine and other function raw materials, extensively plants more than 30 torrid zones, countries, subtropical zone in Asia, Africa and Central America now.Along with the progress of research and exploitation, Moringa more was subject to people's attention in positive day.
Moringa blade, fruit pod comprehensive nutrition and enriching see Table 1, table 2.
Table 1:100g Moringa nutritional labeling
Composition | The fresh fruit pod | Fresh leaves | Blade dry powder | WHO recommends the standard of absorbing every day (0-5 year children/nursing women) |
Protein (g) | 2.50 | 6.70 | 27.10 | 16.00/65.00 |
Calcium (mg) | 30.00 | 440.00 | 2000.30 | 400.00/1200.00 |
Magnesium (mg) | 24.00 | 24.00 | 368.00 | 150.00/340.00 |
Phosphorus (mg) | 110.00 | 70.00 | 204.00 | 800.00/1200.00 |
Potassium (mg) | 259.00 | 259.00 | 1324.00 | 800.00/3000.00 |
Copper (mg) | 3.10 | 1.10 | 0.60 | 0.80/2.00 |
Iron (mg) | 53.00 | 7.00 | 282.00 | 10.00/15.00 |
Vitamin A (mg) | 0.10 | 6.80 | 163.00 | 1.50/5.70 |
Cobastab (mg) | 423.00 | 412.00 | - | - |
Vitamin B1 (mg) | 0.05 | 0.21 | 2.00 | 0.50/1.60 |
Vitamin B2 (mg) | 0.07 | 0.05 | 20.50 | 0.80/1.80 |
Vitamin B3 (mg) | 0.20 | 0.80 | 8.20 | 9.00/20.00 |
Vitamin C (mg) | 120.00 | 220.00 | 173.00 | 20.00/95.00 |
Vitamin E (mg) | - | - | 113.00 | - |
Table 2: amino acid content (g./16gN) and WHO picked-up standard
Amino acid | Blade | Plant benevolence | Meal | Kind benevolence behind the extraction oil | Meal behind the extraction oil | WHO recommends the standard of absorbing every day |
Lysine | 5.60 | 1.41 | 1.47 | 1.62 | 1.48 | 5.80 |
Leucine | 8.70 | 5.11 | 5.27 | 5.85 | 5.84 | 6.60 |
Isoleucine | 4.50 | 2.99 | 3.05 | 3.45 | 3.49 | |
The potassium methyllanthionine | 1.98 | 1.93 | 1.90 | 2.23 | 2.13 | 2.50 |
Cystine | 1.35 | 4.13 | 4.22 | 4.82 | 4.72 | |
Phenylalanine | 6.18 | 3.83 | 3.97 | 4.30 | 4.29 | 6.30 |
Tyrosine | 3.87 | 1.44 | 1.50 | 1.52 | 1.41 | |
Valine | 5.68 | 3.40 | 3.47 | 3.72 | 3.63 | 3.50 |
Histidine | 2.99 | 2.20 | 2.27 | 2.38 | 2.28 | 1.90 |
Alpha-amino-beta-hydroxybutyric acid | 4.66 | 2.15 | 2.25 | 2.41 | 2.28 | 3.40 |
Tryptophan | 2.10 | - | - | - | - | 1.10 |
In 100g fresh flower, browse and the tender pod, the content of calcium, iron, phosphorus, potassium, Cobastab and vitamin A is respectively:
Tender leaf 440mg, 7mg, 70mg, 259mg, 423mg, 6.8mg;
Tender pod 30mg, 53mg, 110mg, 259mg, 423mg, 0.1mg;
Blade dry powder 2003mg, 282mg, 204mg, 1324mg ,-, 163mg.
The content of various mineral matters, little living element and essential amino acid is recommended picked-up standard height than The World Health Organization (WHO).It is reported that calcium and protein content are respectively 4 times and 2 times of milk, potassium is 3 times of banana, and iron is 3 times of spinach, and vitamin C is 7 times of orange, and vitamin A is 4 times of carrot.A lot of developing china family expenses Moringas improve malnutrition, use 25g blade dry powder every day, can obtain 42% protein, 125% calcium, 61% magnesium, 41% potassium, 71% iron, 272% vitamin A and 22% vitamin C of proposed standard.Children below 3 years old, taking after two months, body weight increases 1000g-3500g.
Moringa has brings down a fever, anti-inflammatory, row's stone, diuresis, step-down, pain relieving, cardiac stimulant, urges functions such as desire.India and African country are usually used in treating diseases such as diabetes, hypertension, cardiovascular disease, obesity, skin disease, eye illness, hypoimmunity, scurvy, anaemia, rickets, depression, arthritis, rheumatism, calculus, digestive organs tumour.The external medical health care function that studies have shown that Moringa in a large number: blade, fruit and root contain and bring high blood pressure down and the function composition of cholesterol; Ghasi, people such as S studies show that, leaf of Moringa can reduce the cholesterol 14.35%, 6.40% and 11.09% in serum, liver and the kidney of high fat mouse respectively, and increases by 15.22% haemocyanin; The alkaloid that root is contained can change mouse blood urine element, plasma proteins, bilirubin and cholesterol significantly; Blade contains superoxide dismutase (SOD) and the catalase (CAT) of regulating thyroid hormone and liver fat peroxidation (LPO).Tahiliam.P etc. studies show that with white mouse along with the increase of serum thyroxine [T (4)] concentration, serum triiodothyronine [T (3)] concentration reduces about 30%, proves that the leaf extract of low dosage can be regulated hyperthyroidism; Animal experiment shows, leaf extract can reduce by 25% cholesterol, the Moringa blade contains abundant vitamin A, can treat vitamin(e) A deficiency, Nambjar.V.S etc. studies show that, the Moringa blade can obviously improve the clinical symptoms of vitamin(e) A deficiency, and vitamin A content obviously increases (28.2mug/dL is 19.1mug/dL and contrast) in body weight and the serum.Scholars such as Guevara.A.P studies have shown that in the Moringa seed 4 (thiocarbamate in α-L-rhamnosyloxy)-benzyl isothiocyanate, cupreol-3-O-β-D-glucopyranoside, niazimicin and the Moringa blade all have the obvious suppression effect to Epstein Ba Rui virus (Epstein-Barrvirus), and thiocarbamate fat can suppress the growth of tumour cell.
Moringa only has the Xishuangbanna in Guangdong, Hainan and Yunnan to introduce a fine variety to plant experimentally at home.According to the nutritive value of Moringa uniqueness and China people's health care and drink (water) food health market potential demand, and Moringa wide adaptability, the extensive biological characteristics of cultivation, in China's development Moringa scale plantation and product development good market and commercial promise are arranged.
Milk thistle (Milk Thistle) has another name called " newborn Ji ", and the source dried rhizome of rehmannia is India and Pakistani Kashmir mountain area, now Europe, all plantations of a plurality of areas in America and Australia.Silymarin in the Milk Thistle seed extract (silymarin) has the effect of strengthening liver, reducing fat and repair liver organization, as a kind of naturopathy history in 2000 is nearly arranged as the milk thistle of natural herb plant.
Show in a nearest clinical medicine report of doing at liver diseases, nearly there is 31% sufferer can use some unorthodox therapys to cure the disease, the most normal just a kind of folk custom therapy that is used of the thistle of wherein suckling, and have hepatopath over half to point out nearly, use the milk thistle can improve their symptom really.
The milk thistle contains three kinds of compositions with liver-protecting function, is respectively silibinin, and silidianin and silicristin are referred to as silymarin (silymarin) now.Topmost active material-silymarin (silymarin) in the milk thistle of putting down in writing on the document, it is a kind of compound antioxidant, liver cell is formed layer protecting film, stop toxicant, particularly alcohol and environmental contaminants (agricultural chemicals, heavy metal etc.) invasion damages liver, for the illness of some acute hepatotoxicity, certain detoxicating functions is arranged; Can protect liver cell to avoid free radical and destroy, render a service and outclass vitamin E; Promote the synthetic of protein, accelerate to make new liver cell, or make liver cell in damaged condition repair voluntarily.
The whole strain of milk thistle all can be used, and comprises seed, leaf, stem and tender shoots and root, and silymarin exists only in the seed.
Milk almost contains the various nutriments of needed by human body except that fibre-bearing element not, its Protein content is 3.5-4%.Secondly the composition of its protein is lactoprotein, lactoglobulin, seralbumin, immunoglobulin (Ig) and enzyme etc. based on casein, can supply the essential of human body effectively.The biological value of milk protein can compare favourably with eggs, is the higher high-quality protein of lysine, methionine content, has replenished the deficiency that all kinds of gal4 amino acids are formed.Cholesterol level is not high in the milk, and the orotic acid that wherein contains also can reduce serum cholesterol.The fat content of milk is 3-4%, and its lipochondrion is very little, is the high degree of dispersion state, thereby the digestibility height.Also contain linoleic acid, lecithin and a small amount of cholesterol in the butterfat.Carbohydrate in the milk is 4-6%, is mainly lactose.Lactose has adjusting hydrochloric acid in gastric juice, promotes the secretion of gastrointestinal peristalsis and glandula digestive, and can promote the breeding of Bacillus acidi lactici, suppresses the growth of pathogenic bacteria and spoilage organisms, helps the activity and the breeding of normal flora in the enteron aisle.Micronutrient levels such as calcium, phosphorus, potassium are abundant in the milk, every liter of milk can provide the calcium of 1200mg, and utilization very easily is absorbed by the body, many drink milks are the easier absorption of more oral calcium tablet than the every day, GI irritation still less, being to replenish the calcareous preferably source of children, also is the best tonic of prevention middle-aged and senile osteoporosis, and has kept the balance of human body acid-base effectively.
In China, quickening and growth in the living standard along with people's rhythm of life, the irrational problem of dietary structure is outstanding day by day, as nutritional labeling deficiencies such as people's diet ubiquity calcium, iron, potassium, vitamin As, chronic disease incidences such as obesity, cardiovascular disease, cancer are more and more higher among the crowd, and gradually to the development that becomes younger.
Therefore be necessary to provide a kind of milk product of nutritional labeling equilibrium.
Summary of the invention:
The object of the invention is to provide a kind of milk powder, specifically, provides a kind of milk powder product that contains Moringa leaf extract and Semen Herba Silybi mariani extract.
Another object of the present invention provides a kind of preparation method of milk powder, provides the preparation method of above-mentioned milk powder specifically.
In the milk powder of the present invention, the weight portion proportioning of the mixture of milk powder and Moringa blade and Semen Herba Silybi mariani dry powder is 100: 0.5-2.0 is preferably 100: 1-1.5.
Above-mentioned milk powder product also can add the sugar of 1-3% weight portion as required.Described sugar can be lactose, white granulated sugar, sucrose, soyabean oligosaccharides.
Weight in the mixture of above-mentioned Moringa blade and Semen Herba Silybi mariani dry powder consists of:
Moringa blade dry powder 0-99%
Semen Herba Silybi mariani dry powder 1-100%.
The mixture composition of above-mentioned Moringa blade and Semen Herba Silybi mariani dry powder is preferably:
Moringa blade dry powder 70-90%
Semen Herba Silybi mariani dry powder 10-30%.
The mixture composition of above-mentioned Moringa blade and Semen Herba Silybi mariani dry powder most preferably is:
Moringa blade dry powder 85-90%
Semen Herba Silybi mariani dry powder 10-15%.
Above-mentioned Moringa leaf extract is preferably dry powder, and the Semen Herba Silybi mariani extract is preferably dry powder.
The method of the invention comprises the preparation of Moringa leaf extract, the preparation of Semen Herba Silybi mariani extract and the preparation of milk powder product.
The preparation process of described Moringa blade dry powder is: get the Moringa blade, residual leaf, petiole are extractd, make blade pure; Wash with water purification and to float, remove earth, the impurity on surface; At 120-200 ℃ of wink-dry, be not more than 1min drying time, to avoid destroying nutritional labeling; The cooling of dry back under the situation that does not get damp again, is ground at once; With 130-150 mesh sieve sieve powder, obtain Moringa blade dry powder;
The preparation process of described Semen Herba Silybi mariani dry powder is: treat that Milk Thistle connects petal when just ripe and gathers immediately, avoid cracking to be scattered, dry immediately after gathering, regather seed; Seed is placed in the pot of preheating, slow fire is fried to seed little defocused, and according to the consumption of 200ml vinegar/1kg seed, spray vinegar makes it even absorption while frying, after treating that thing is fragrant and overflowing, takes out airing, under the situation that does not get damp again, and grinding at once; With 130-150 mesh sieve sieve powder, obtain Semen Herba Silybi mariani dry powder;
Described method for preparing milk is: fresh milk is concentrated, obtain concentrating breast, obtain the dry powder breast through spray-drying again, the dry powder breast is mixed in proportion with Moringa blade dry powder and Semen Herba Silybi mariani dry powder behind cooling, sieve powder, obtains milk powder product through post processing.
Milk-powder brewing method of the present invention: 200 milliliters of warm water+30 gram milk powder
In the Moringa leaf extract, various nutritional labelings are as follows:
Wherein, in the Semen Herba Silybi mariani blade dry powder, various nutritional labelings are as follows, see Table 3:
Element | Magnesium | Calcium | Zinc | Iron | Copper | Manganese | Selenium |
Content μ molKg -1 | 4.85-5.92 | 3.62-4.94 | 1.67-1.79 | 0.25-0.28 | 0.107-0.123 | 18.00-22.00 | 6.46-7.47 |
Magnesium is the necessary element of cell metabolism, participates in some relevant energy transfers in the body, has lax neural effect, is one of composition of bone.
Calcium can be kept the complete of bone and healthy tooth, regulates nerve excitability, the conveying function when being stimulated, influence contraction of muscle and blood aggegation, keep regular heartbeat, relax some little effectiveness of insomnia aspect, help the metabolism of iron in the body.
Zinc is the necessary element of bodily tissue and body fluid, promotes growth, the growth of sexual organ, wound healing, participates in skin, hair, nail, and the repairing effect of plurality of positions such as mucous membrane of mouth, participates in DNA, RNA, histone is synthetic and repairing.
Iron participates in making the formation of sclerotin collagen (collagen), it is the raw material in the immune system, it is the important component of the red globulin of ferroheme, flesh (myoglobin), and ferroheme is erythrocytic constituent, can carry oxygen to whole body everywhere, experiment confirm, an amount of iron can be used for anticancer, prevent anaemia, synthetic cell pigment in the mitochondria helps the formation of free radical.
Copper is one of main component of making in cell and tissue, constitute the key element of skin chromaticness, the ferment of cupric has oxidation resistance, can alleviate and prevent inflammation, promote the utilization of iron, keep the development of connective tissue, nerve and bone, promote the normal operation of immune system, blood coagulation system, cardiovascular system.
Manganese is the constituent of many ferment, so participate in advancing of some metabolic responses, promotes the effect of insulin, keeps normal blood coagulation mechanism, safeguards the development of bone and connective tissue, the normal operation of short nervous centralis.
Selenium has antitumaous effect, can eliminate the peroxide that has formed, and has protective tissue, cell membrane, anti-oxidation destruction.
Trace element has important function to eubolism and the function of keeping human body, and liver is important metabolism organ, in close relations with trace element.
Chronic hepatitis patient exists metabolism of trace elements unusual; selenium is the trace element of needed by human; with being related closely of hepatitis; selenium is also referred to as the hepatonecrosis protection factor; low selenium is one of factor that causes hepatonecrosis; microelement deficiencies or excess energy cause the dysbolism of plurality of enzymes system in the body or are suppressed in addition, and cause a series of metabolic disorders and pathological change, so that increase the weight of the state of an illness of chronic hepatitis.
Selenium in the Milk Thistle, zinc content are very high, and suitably selenium, the zinc content in the added body makes in-vivo element be in normal level, and manganese plays an important role to the function of enzyme, corrects the shortage or the surplus of chronic hepatitis patient trace element.
Trace element has hepatoprotective effect in the Milk Thistle, corrects the effect of metabolic disorder, can promote liver cell regeneration and strengthen machine-processed anti-infection ability.
Table 4: Milk Thistle (seed) total protein and albumin amino acid content (g/100g protein)
Classification | Essential amino acid | Total protein | Albumin | |
Aliphatic amino acid | Neutral | Crisp propylhomoserin Thr | 3.17 | 2.88 |
A word used in person's names propylhomoserin Val | 4.81 | 5.65 | ||
Leucine Leu | 5.65 | 5.91 | ||
Isoleucine Ile | 3.71 | 4.46 | ||
Methionine Met | 0.71 | 1.10 | ||
Alkalescence | From propylhomoserin Lys | 6.37 | 2.55 | |
Aromatic amino acid (neutrality) | Phenylalanine Phe | 3.42 | 4.74 | |
Different ring family's amino acid (neutrality) | Tryptophan Trp | --- | ---- | |
The His of histidine | 4.73 | 2.66 |
Table 5:
Classification | Nonessential amino acid | Total protein | Albumin | |
Aliphatic amino acid | Neutral | Glycine Gly | 4.9*5 | 4.51 |
Alanine Ala | 3.73 | 4.04 | ||
Serine Ser | 3.71 | 4.54 | ||
Cysteine Cys | 3.00 | 1.71 | ||
Cystine Cystine | --- | --- | ||
Acid | Aspartic acid Asp | 8.21 | 10.49 | |
Sulphur ammonia aspartic acid Asn | --- | --- | ||
Skin propylhomoserin Glu | 20.06 | 23.42 | ||
Sulphur ammonia skin propylhomoserin Gln | --- | --- | ||
Alkalescence | Arginine Arg | 10.30 | 8.38 | |
Citrulling Cit | --- | --- | ||
Aromatic amino acid (neutrality) | Tyrosine Tyr | 2.88 | 3.96 | |
Different ring family's amino acid (neutrality) | Proline Pro | 4.58 | 5.00 | |
Hydroxyproline Hyp | --- | --- |
Protein is the raw material that forms various organs of health and tissue, also is various hormonal main components in the body, and regulates various physiological functions, and health does not need protein in the neither one place up and down.
Lack protein, health can descend to the resistance of disease, and the interior redundant moisture of body can't be discharged, and causes oedema, also can make muscle follow the string hair variable color, growth retardation, indigestion, blood cell and hormone can't be made, and last internal organs are degenerated depleted, cause death.
Protein content is a height with soya bean, egg, these three kinds of modal food of milk, its contained protein all is unusual excellent protein, but egg and soya bean contain higher grease, more or less fear for the most of moderns that pursue weight reducing, the high cholesterol count of egg is again the another one restriction for the people that the angiocardiopathy misgivings are arranged.
Protein is a general name, is to be made of amino acid, kind surplus amino acid has 20, some amino acid can be transformed by other amino acid in the human liver, is called nonessential amino acid, and some amino acid liver can not oneself synthesize, must obtain by food, be called essential amino acid.
The nutritionist in the quality quality of evaluating protein matter whether, whether the ratio of seeing essential amino acid exactly conforms with needed by human body is wanted.
Table 4,5 analysis results show that the amino acid of Semen Herba Silybi mariani is formed three characteristics:
(1) Lys (6.37%>5.50%) Met+Cys (3.71%>3.50%) Phe+Tyr (6.30%>6.00%) content has all surpassed the corresponding index of FAO/WHO suggestion, other essential amino acids, as: Thr, Val, Ile, Leu etc. are very near the index of FAO/WHO.
(2) seed albumen is rich in acidic amino acid Glu and Asp and basic amino acid Arg and Lys.
(3) albuminised amino acid composition is consistent with the total protein performance substantially, illustrates that it is the main constituent of total protein really.
In addition, cholesterol only is present in animal food, and contained in the plant food have plenty of the chemical constitution phytosterol close with cholesterol, can prevent the deposition of cholesterol in human body.
The protein that Semen Silybi mariani dry powder and Moringa blade dry powder are contained is the composition and the content of high protein, zero cholesterol, trace element, and both complement each other, and have the effect of maintenance again.
Researcher of the present invention finds, with regard to Moringa leaf extract and Semen Herba Silybi mariani extract, existing application in food, health products separately, but as single a kind of nutritional supplements, the nutritional labeling of himself has unbalanced part more, often can not satisfy the normal need of human body, Moringa only on calcium, iron, vitamin A, vitamin B1, vitamin B2, these several indexs of vitamin C content higher, unless under the enough big prerequisite of intake, be the needs that can not satisfy the normal human on nickel, zinc, iron, copper, manganese, these several indexs of selenium; And Semen Herba Silybi mariani dry powder at calcium, iron, vitamin A, vitamin B1, vitamin B2, vitamin C obviously is the requirement of not satisfying WHO.Based on this kind situation, researcher of the present invention finds, when the weight ratio of Moringa blade dry powder and Semen Herba Silybi mariani dry powder is controlled at 8: 1 left and right sides, is applied to milk powder, not only nutritional labeling can reach every related standards of WHO, and can realize minimum intake.Under the guidance of this discovery, product of the present invention has the good result that various nutriment simple superposition are not had, can either satisfy the demand of human body, avoid the excessive or not enough of certain several nutrient intake again, make the trophic structure of milk powder more be tending towards balanced various nutrition compositions.
Liver is the vitals of human body, all foods all will could be utilized by human body through the conversion of liver after alimentary canal absorbs, harmful substance enter filtration and the processing that also needs through liver, so the infringement to human body that various food caused that human body is taken in, liver always stands in the breach.Therefore, although liver has the function of self-regeneration, the food that also needs the rhythm of life of rational rest and maintenance, rule to become reconciled is protected.Because the filtration detoxication of liver, the conventional method that protects the liver is tonic but not medicine doctor, the diet principle of love liver is exactly the food of having more meals a day but less food at each, eating as far as possible high heat, high protein, homovitamin, low fat, low sugar, so, product of the present invention is by reasonably combined, when satisfying the good absorption and utilization of human body to nutritional labeling, cooperate the existing liver components that protects in the milk thistle, formed a kind of satisfy human body to the nutriment needs in, the food that can have more meals a day but less food at each is that food is safeguarded in a kind of good protecting the liver.
Milk powder of the present invention can be made traditional milk powder (skimmed milk powder, whole-fat milk powder), baby's milk powder (it is refining to measure body in addition) or other pattern milk powder, effect aspect nutrition and health care significantly improves than like product, has augment nutritional, dietotherapy, the effect of health care, be the pregnant woman, the nursing women, infant's nutrient supplement food, it is again supplement calcium, strong bone, the health food of prevention of osteoporosis disease, the loss of bleeding that menstruation causes for the women, childbearing age is to the insufficiency of intake of irony, vegetarian diet group is to the insufficiency of intake of nutrient, all can play the effect of alleviating or remedying, be the food of enriching blood of high-quality.
Milk-powder brewing method of the present invention: 200 milliliters of warm water+30 gram milk powder
Description of drawings
Fig. 1 is the preparation flow figure of embodiment 1
Fig. 2 is the preparation flow figure of embodiment 2
The specific embodiment
Embodiment 1
Fresh milk obtains concentrating breast through concentrating, and passes through the compression pump high-pressure spray-drying again, obtains dry powder breast 1.7kg behind the cooling sieve powder; Mix with Moringa blade dry powder 15g, Semen Herba Silybi mariani dry powder 3g, obtain milk powder product through post processing.
Present embodiment milk powder and commercially available whole milk powder nutrition comparison sheet (every 100g average content)
Whole milk powder | Present embodiment | |
% protein: | 26.3 | 31 |
(mg) calcium: | 912 | 1212 |
(mg) phosphorus: | 776 | 806 |
(mg) sodium: | 371 | 371 |
(mg) magnesium: | 85 | 140 |
(mg) potassium: | 1330 | 1530 |
(mg) iron: | 0.5 | 43 |
The % carbohydrate: | 38.2 | 44 |
The % dietary fiber: | 0 | 32 |
(mg) bata-carotene: | 922IU | 922IU+25 |
(mg) vitamin C: | 0 | 25 |
Embodiment 2
Fresh milk obtains concentrating breast through concentrating, and adds soyabean oligosaccharides 2.1g, passes through centrifugal spray drying again, obtains dry powder breast 2.0kg behind the cooling sieve powder, mixes with Moringa blade dry powder 44g, Semen Herba Silybi mariani dry powder 6g, obtains milk powder product through post processing.
Present embodiment product and the preceding comparison of dry powder breast aspect nutrient composition content of interpolation:
The base stock nutrient composition content | Add the back nutrient composition content | |||
Composition | Per 100 grams | Cup/32.5 grams | Per 100 grams | Cup/32.5 grams |
Lipid g | 28.00 | 9.10 | 28.18 | 9.16 |
Protein g | 24.00 | 7.80 | 26.17 | 8.51 |
Calcium mg | 912.00 | 296.00 | 1072.03 | 348.41 |
Phosphorus mg | 720.00 | 234.00 | 736.32 | 239.31 |
Sodium mg | 371.00 | 120.58 | 371.00 | 120.58 |
Magnesium mg | 85.00 | 27.63 | 114.44 | 37.20 |
Potassium mg | 1330.00 | 432.26 | 1436.92 | 467.00 |
Iron mg | 0.50 | 0.16 | 2.76 | 0.90 |
Carbohydrate % | 38.20 | 12.42 | 41.26 | 13.41 |
Vitamin A IU/mg | 922IU | 300IU | 922IU 1.31mg | 300IU 0.43mg |
Vitamin B1/mg | 0.30 | 0.10 | 0.51 | 0.17 |
Vitamin B2/mg | 1.21 | 0.40 | 2.85 | 0.93 |
Vitamin C/mg | --- | --- | 13.84 | 4.50 |
Amino acid | Trace | Trace | Than nutrient composition content height |
Claims (6)
1, a kind of milk powder, it is characterized in that, described milk powder contains Moringa blade dry powder and Semen Herba Silybi mariani dry powder, the weight portion proportioning of the mixture of milk powder and Moringa blade dry powder and Semen Herba Silybi mariani dry powder is 100: 0.5-2.0, wherein the weight of Moringa blade dry powder consists of 70-90% in the mixture of Moringa blade dry powder and Semen Herba Silybi mariani dry powder, and the weight of Semen Herba Silybi mariani dry powder consists of 10-30%.
2, milk powder according to claim 1 is characterized in that, the weight portion proportioning of the mixture of milk powder and Moringa blade dry powder and Semen Herba Silybi mariani dry powder is 100: 1-1.5.
3, milk powder according to claim 1 and 2 is characterized in that, adds the sugar of 1-3% weight portion in the described milk powder.
4, milk powder according to claim 3 is characterized in that, described sugar is lactose, white granulated sugar, sucrose or soyabean oligosaccharides.
5, milk powder according to claim 1 is characterized in that, the weight of the mixture of described Moringa blade dry powder and Semen Herba Silybi mariani dry powder consists of:
Moringa blade dry powder 85-90%
Semen Herba Silybi mariani dry powder 10-15%.
6, the preparation method of any one described milk powder of claim 1-5 is characterized in that, described method comprises the preparation of Moringa blade dry powder, the preparation of Semen Herba Silybi mariani dry powder and the preparation of milk powder product,
The preparation process of described Moringa blade dry powder is: get the Moringa blade, residual leaf, petiole are extractd, make extract pure; Wash with water purification and to float, remove earth, the impurity on surface; At 120-200 ℃ of wink-dry, be not more than 1min drying time, to avoid destroying nutritional labeling; The cooling of dry back under the situation that does not get damp again, is ground at once; With 130-150 mesh sieve sieve powder, obtain Moringa blade dry powder;
The preparation process of described Semen Herba Silybi mariani dry powder is: treat that Milk Thistle connects petal when just ripe and gathers immediately, avoid cracking to be scattered, dry immediately after gathering, regather seed; Seed is placed in the pot of preheating, slow fire is fried to seed little defocused, and according to the consumption of 200ml vinegar/1kg seed, spray vinegar makes it even absorption while frying, after treating that thing is fragrant and overflowing, takes out airing, under the situation that does not get damp again, and grinding at once; With 130-150 mesh sieve sieve powder, obtain Semen Herba Silybi mariani dry powder;
Described method for preparing milk is: fresh milk is concentrated, obtain concentrating breast, obtain the dry powder breast through spray-drying again, the dry powder breast is mixed in proportion with Moringa blade dry powder and Semen Herba Silybi mariani dry powder behind cooling, sieve powder, obtains milk powder product through post processing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100483874A CN1315391C (en) | 2004-06-30 | 2004-06-30 | Milk powder and its preparing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100483874A CN1315391C (en) | 2004-06-30 | 2004-06-30 | Milk powder and its preparing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1714658A CN1714658A (en) | 2006-01-04 |
CN1315391C true CN1315391C (en) | 2007-05-16 |
Family
ID=35821075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100483874A Expired - Fee Related CN1315391C (en) | 2004-06-30 | 2004-06-30 | Milk powder and its preparing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1315391C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104381445A (en) * | 2014-12-18 | 2015-03-04 | 云南皇氏来思尔乳业有限公司 | Moringa yogurt and preparation method thereof |
CN107494743A (en) * | 2017-07-31 | 2017-12-22 | 安徽恋尚你食品有限公司 | A kind of instant Kiwi berry Moringa milk powder |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1123606A (en) * | 1994-11-26 | 1996-06-05 | 宁夏中宁县永兴保健食品厂 | Chinese wolfberry soyabean milk powder and its production |
CN1422534A (en) * | 2002-11-26 | 2003-06-11 | 锡林郭勒盟鑫泰生物制品有限责任公司 | Peptide milk powder and its preparation technology |
CN1425311A (en) * | 2003-01-13 | 2003-06-25 | 许立壮 | Soybean oligose milk product and its preparing method |
CN1442066A (en) * | 2003-03-25 | 2003-09-17 | 汕头市金园区丹味食品发展中心 | Milk powder and its preparation method |
-
2004
- 2004-06-30 CN CNB2004100483874A patent/CN1315391C/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1123606A (en) * | 1994-11-26 | 1996-06-05 | 宁夏中宁县永兴保健食品厂 | Chinese wolfberry soyabean milk powder and its production |
CN1422534A (en) * | 2002-11-26 | 2003-06-11 | 锡林郭勒盟鑫泰生物制品有限责任公司 | Peptide milk powder and its preparation technology |
CN1425311A (en) * | 2003-01-13 | 2003-06-25 | 许立壮 | Soybean oligose milk product and its preparing method |
CN1442066A (en) * | 2003-03-25 | 2003-09-17 | 汕头市金园区丹味食品发展中心 | Milk powder and its preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN1714658A (en) | 2006-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100914065B1 (en) | Wire meal using wild grass and wire drink | |
US20090098230A1 (en) | Nutraceutical moringa composition | |
Gaweł et al. | Lucerne (Medicago sativa L.) in the human diet—Case reports and short reports | |
CN103355555A (en) | Feed for laying hen in egg-laying peak stage and preparation method thereof | |
CN103355544B (en) | Lactation sow forage | |
CN101822383A (en) | Functionality nutritional meal replacing food suitable for tumor patient and preparation method thereof | |
CN102048210A (en) | Red-date health protection beverage with function of alleviating fatigue | |
CN102178183A (en) | Five-bean comprehensive nutritional food | |
KR20090101397A (en) | Functional eat uncooked food powder mixed medicinal herbs | |
CN102048225A (en) | Red-date health protection beverage capable of improving growing development | |
CN103610144A (en) | Walnut powder with blood glucose reduction effect and preparation method thereof | |
KR20010084126A (en) | Manufacturing method for noodles | |
CN109123614A (en) | A kind of black nutritive meal preparation for being suitable for spacefarer and eating | |
CN100367861C (en) | Bread and its preparing method | |
CN1315392C (en) | Bean milk powder and its preparing method | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
CN108782679A (en) | A kind of weight-reducing intervention is dry and preparation method thereof for refreshment | |
CN1315403C (en) | Instant noodle and its preparing method | |
CN1315391C (en) | Milk powder and its preparing method | |
CN105166653A (en) | Stomach-invigorating and health-preserving sweet potato gruel and preparing method thereof | |
CN1315410C (en) | Edible composition and its preparing method | |
KR102082115B1 (en) | Manufacturing method of healthy foods using protaetia brevitarsis | |
Arya | Food is your Medicine | |
KR20100042078A (en) | Dietary food constituents | |
CN105495584A (en) | Production method of peanut protein-based food capable of enhancing body immunity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070516 Termination date: 20100630 |